Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomal dominant retinitis pigmentosa and the pro-23-his mutation
- PMID: 7601641
Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomal dominant retinitis pigmentosa and the pro-23-his mutation
Abstract
Purpose: The leading edge of the rod a-wave in normal human subjects can be fit with a computational model of the activation phase of transduction to provide parameters analogous to those obtained from individual photoreceptors. The authors extend this work to the kinetics of recovery after saturating flashes.
Methods: Electroretinograms were recorded from three patients with autosomal dominant retinitis pigmentosa and the pro-23-his rhodopsin mutation, two patients with rod monochromatism, and five normal subjects. Rod-only a-waves were obtained for a series of flashes ranging from 4.4 to 10.1 ln (1.9 to 4.4 log) scot td-sec. One set of parameters describing the activation process was derived from fits to the a-wave model. A double-flash paradigm was used to study inactivation mechanisms. The first flash was achromatic and varied in intensity (I(f)) from 6.1 to 13.9 ln (2.6 to 6.0 log) scot td-sec. The second flash was a short-wavelength probe held constant at 9.3 ln (4.0 log) scot td-sec. Cone components were elicited with a photopically matched long-wavelength stimulus and were computer subtracted. Recovery at each I(f) was followed by measuring the amplitude to the probe flash at various interstimulus intervals (ISI). The critical time (Tc) before the initiation of rod recovery was determined from the function relating relative rod amplitude to ISI.
Results: Recovery from activation was similar in normal subjects and in patients with rod monochromatism. Over a large range of I(f) above rod saturation, Tc increased in proportion to ln I(f). The mean slope of the function relating Tc to I(f) was 2.3 s/ln I(f) when I(f) varied between 11 and 13.9 ln scot td-sec. Patients with retinitis pigmentosa and the pro-23-his rhodopsin mutation had a decrease in the gain of activation. They also had significantly slower than normal recovery after high test flash intensities, such that the slope of the function relating Tc to ln I(f) was 12.1 seconds.
Conclusion: Available data from other species imply that complete, transient activation of transducin (T saturation) occurs within or below the investigated range of flash intensities. Based on the slope of the delay function (delta Tc/ delta ln I(f)) above 11 ln scot td-sec, the authors hypothesize that the lifetime of activated rhodopsin (R) in normal human rods is approximately 2.3 seconds. In patients with the pro-23-his mutation, the gain of the activation mechanism is reduced and the reaction determining the delta Tc/ delta ln I(f) slope is markedly slowed. The activated species that exhibits this prolonged lifetime could be the mutant rhodopsin itself.
Similar articles
-
Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave.Invest Ophthalmol Vis Sci. 1994 Jun;35(7):2948-61. Invest Ophthalmol Vis Sci. 1994. PMID: 8206712
-
Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation.Invest Ophthalmol Vis Sci. 1995 Oct;36(11):2186-92. Invest Ophthalmol Vis Sci. 1995. PMID: 7558711
-
Rod phototransduction in retinitis pigmentosa. Distinguishing alternative mechanisms of degeneration.Invest Ophthalmol Vis Sci. 1995 May;36(6):1027-37. Invest Ophthalmol Vis Sci. 1995. PMID: 7730012
-
Retinitis pigmentosa: unfolding its mystery.Proc Natl Acad Sci U S A. 1996 May 14;93(10):4526-8. doi: 10.1073/pnas.93.10.4526. Proc Natl Acad Sci U S A. 1996. PMID: 8643437 Free PMC article. Review. No abstract available.
-
Rhodopsin, Zn(2+), and retinitis pigmentosa: a short tale requiring continuation.Biochemistry (Mosc). 2013 Jun;78(6):660-6. doi: 10.1134/S0006297913060114. Biochemistry (Mosc). 2013. PMID: 23980892 Review.
Cited by
-
Flicker assessment of rod and cone function in a model of retinal degeneration.Doc Ophthalmol. 2007 Nov;115(3):165-72. doi: 10.1007/s10633-007-9066-9. Epub 2007 Aug 3. Doc Ophthalmol. 2007. PMID: 17674067
-
Progressive reduction of its expression in rods reveals two pools of arrestin-1 in the outer segment with different roles in photoresponse recovery.PLoS One. 2011;6(7):e22797. doi: 10.1371/journal.pone.0022797. Epub 2011 Jul 26. PLoS One. 2011. PMID: 21818392 Free PMC article.
-
CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function.Invest Ophthalmol Vis Sci. 2014 Sep 9;55(10):6301-8. doi: 10.1167/iovs.14-14860. Invest Ophthalmol Vis Sci. 2014. PMID: 25205868 Free PMC article. Clinical Trial.
-
R9AP stabilizes RGS11-G beta5 and accelerates the early light response of ON-bipolar cells.Vis Neurosci. 2010 Mar;27(1-2):9-17. doi: 10.1017/S0952523809990319. Epub 2010 Jan 26. Vis Neurosci. 2010. PMID: 20100392 Free PMC article.
-
Misregulation of rhodopsin phosphorylation and dephosphorylation found in P23H rat retinal degeneration.Clin Ophthalmol. 2008 Dec;2(4):821-8. doi: 10.2147/opth.s4359. Clin Ophthalmol. 2008. PMID: 19668436 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources